SECRETED OVARIAN STROMAL SUBSTANCE INHIBITS OVARIAN EPITHELIAL-CELL PROLIFERATION

被引:23
作者
KARLAN, BY [1 ]
BALDWIN, RL [1 ]
CIRISANO, FD [1 ]
MAMULA, PW [1 ]
JONES, J [1 ]
LAGASSE, LD [1 ]
机构
[1] GENET THERAPY INC,GAITHERSBURG,MD 20878
关键词
D O I
10.1006/gyno.1995.1269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Determine the effects of factors secreted by normal human ovarian stroma on the proliferation of benign and malignant ovarian epithelia, in vitro. Methods: Primary cultures of normal human ovarian surface epithelium (HOSE), human ovarian stromal tissue (HOST), and epithelial ovarian carcinomas (CSOC) were established from surgical specimens and characterized immunohistochemically using anti-cytokeratin, vimentin, and; Factor Vm antibodies. Stroma-conditioned media (SCM) were collected over 3 days from confluent HOST cultures. The SCM were dialyzed, lyophilized, resuspended, and added to HOSE, CSOC, SKOV-3, and Caov-3 ovarian cancer cell cultures and growth inhibitory effects were assayed by MTS and [H-3]thymidine uptake. Results: SCM inhibited the growth and DNA synthesis oil normal HOSE cells and cancer cells by 79-99% in >10-cell lines studied to date. The inhibitory effect was rapid in onset with 31-82% reduction in DNA synthesis at 1 hr and approximately 50% return of activity by 23 hr following a 1-hr SCM pulse treatment. The SCM inhibitory activity was not abolished by boiling or by absorption with heparin-agarose. Size exclusion filtration places the molecular weight of the inhibitory substance between 1 and 3 kDa. Neither trypsin nor proteinase K treatments altered the inhibitory activity of SCM, while a Bligh-Dyer organic extraction placed the activity in the aqueous phase. Conclusion: A heat-stable, non-heparin-binding, low-molecular-weight, water-soluble substance secreted by normal ovarian stroma significantly inhibits HOSE and ovarian cancer cell proliferation. Derangements in normal ovarian stroma-epithelial interactions may contribute to growth dysregulation of the surface epithelia and result in ovarian carcinogenesis. (C) 1995 Academic Press, Inc.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 34 条
  • [1] AUERSPERG N, 1984, IN VITRO CELL DEV B, V20, P743
  • [2] SURFACE CELLS OF THE OVARY AND PELVIC PERITONEUM - HISTOCHEMICAL AND ULTRASTRUCTURE COMPARISON
    BLAUSTEIN, A
    LEE, H
    [J]. GYNECOLOGIC ONCOLOGY, 1979, 8 (01) : 34 - 43
  • [3] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [4] CANCER STATISTICS, 1994
    BORING, CC
    SQUIRES, TS
    TONG, T
    MONTGOMERY, S
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1994, 44 (01) : 7 - 26
  • [5] DECOSSE JJ, 1975, J NATL CANCER I, V54, P913
  • [6] DONJACOUR AA, 1992, REGULATORY MECHANISM, P335
  • [7] FROMM GL, 1990, OBSTET GYNECOL, V75, P89
  • [8] MORPHOGENESIS OF HUMAN-COLON CANCER-CELLS WITH FETAL-RAT MESENCHYMES IN ORGAN-CULTURE
    FUKAMACHI, H
    MIZUNO, T
    KIM, YS
    [J]. EXPERIENTIA, 1986, 42 (03): : 312 - 315
  • [9] BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS
    FUTREAL, PA
    LIU, QY
    SHATTUCKEIDENS, D
    COCHRAN, C
    HARSHMAN, K
    TAVTIGIAN, S
    BENNETT, LM
    HAUGENSTRANO, A
    SWENSEN, J
    MIKI, Y
    EDDINGTON, K
    MCCLURE, M
    FRYE, C
    WEAVERFELDHAUS, J
    DING, W
    GHOLAMI, Z
    SODERKVIST, P
    TERRY, L
    JHANWAR, S
    BERCHUCK, A
    IGLEHART, JD
    MARKS, J
    BALLINGER, DG
    BARRETT, JC
    SKOLNICK, MH
    KAMB, A
    WISEMAN, R
    [J]. SCIENCE, 1994, 266 (5182) : 120 - 122
  • [10] GODWIN AK, 1993, CANCER-AM CANCER SOC, V71, P530